Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-04-22

Clinical Trial Update: SR-T100 Gel Efficacy & Safety Study for Vulva Pre-cancerous Lesions & Cutaneous Condyloma [EARLY_Phase 1]

View source ↗

Summary

A completed early-phase 1 trial evaluating the efficacy and safety of SR-T100 Gel for vulvar intraepithelial neoplasia and genital warts.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SR-T100 Gel

Snippet

Sponsor: National Cheng-Kung University Hospital | Conditions: Vulvar Intraepithelial Neoplasia, Genital Warts | EARLY_Phase 1 | Status: COMPLETED